Alcohol use disorder relapse factors: A systematic review

W Sliedrecht, R de Waart, K Witkiewitz, HG Roozen - Psychiatry Research, 2019 - Elsevier
A relapsing-remitting course is very common in patients with an Alcohol Use Disorder
(AUD). Understanding the determinants associated with alcohol resumption remains a …

Expanding the continuum of substance use disorder treatment: Nonabstinence approaches

CE Paquette, SB Daughters, K Witkiewitz - Clinical Psychology Review, 2022 - Elsevier
Only a small minority of people with substance use disorders (SUDs) receive treatment. A
focus on abstinence is pervasive in SUD treatment, defining success in both research and …

The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder

VI Reus, LJ Fochtmann, O Bukstein… - American Journal of …, 2018 - Am Psychiatric Assoc
The goal of this guideline1 is to improve the quality of care and treatment outcomes for
patients with alcohol use disorder (AUD), as defined by DSM-5 (American Psychiatric …

State-of-the-art behavioral and pharmacological treatments for alcohol use disorder

LA Ray, S Bujarski, E Grodin, E Hartwell… - The American journal …, 2019 - Taylor & Francis
Background: Alcohol use disorder (AUD) and its associated consequences remain
significant public health concerns. Given that AUD represents a spectrum of severity …

Controlled drinking—Non‐abstinent versus abstinent treatment goals in alcohol use disorder: A systematic review, meta‐analysis and meta‐regression

J Henssler, M Müller, H Carreira, T Bschor, A Heinz… - …, 2021 - Wiley Online Library
Abstract Background and Aims The proportion of untreated patients with alcohol use
disorder (AUD) exceeds that of any other mental health disorder, and treatment alternatives …

Reduced drinking in alcohol dependence treatment, what is the evidence?

K Mann, HJ Aubin, K Witkiewitz - European Addiction Research, 2017 - karger.com
Abstinence from alcohol has been the prevailing treatment goal for individuals with alcohol
dependence (AD) within the context of specialty alcohol treatment. Yet, alcohol use has …

Predictors of naltrexone response in a randomized trial: reward-related brain activation, OPRM1 genotype, and smoking status

JP Schacht, PK Randall, PK Latham… - …, 2017 - nature.com
Naltrexone reduces drinking among individuals with alcohol use disorders (AUDs), but it is
not effective for everyone. Variability in its effects on reward-related brain activation, genetic …

Understanding low treatment seeking rates for alcohol use disorder: a narrative review of the literature and opportunities for improvement

A Venegas, S Donato, LR Meredith… - The American journal of …, 2021 - Taylor & Francis
Despite a well-documented global burden of disease attributable to alcohol use disorder
(AUD), treatment seeking rates remain low. In this qualitative literature review, we address …

Voluntary temporary abstinence from alcohol during “Dry January” and subsequent alcohol use.

RO de Visser, E Robinson, R Bond - Health Psychology, 2016 - psycnet.apa.org
Objective: Research suggests that temporary abstinence from alcohol may convey
physiological benefits and enhance well-being. The aim of this study was to address a lack …

Alcohol use disorder: pathophysiology, effects, and pharmacologic options for treatment

RC Wackernah, MJ Minnick, P Clapp - Substance abuse and …, 2014 - Taylor & Francis
Alcohol use disorders (AUD) continue to be a concerning health issue worldwide. Harmful
alcohol use leads to 2.5 million deaths annually worldwide. Multiple options exist for the …